experimental cholera caused by vibrios of the El Tor biotype in the infant mouse and in the rabbit intestinal loop models. MSHA-specific Fab immunoglobulin fragments were also protective. No protective effect was observed against challenge with V. chokerae 01 of the classical biotype. These results suggest that MSHA pfli play an important role in the pathogenesis of cholera caused by the El Tor biotype of V. cholerae and that induction of intestinal anti-MSHA immunity may be a worthwhile additional objective in the development of oral cholera vaccines.
librio cholerae 01 is the causative agent of epidemic cholera. V. cholerae exists as two biotypes, classical and El Tor, and as two main serotypes, Inaba and Ogawa. Cholera disease is caused by the action of cholera toxin, which through its stimulation of intestinal adenylate cyclase activity gives rise to the characteristic excessive electrolyte secretion and fluid loss from the small intestine. However, colonization of the small intestine by V. cholerae strains is also an essential step in the pathogenesis. Different putative adhesive factors have been proposed to be involved in colonization (5-7, 14, 15) . One of these, a toxin-coregulated pilus has been shown to be important for colonization of V. cholerae 01 of the classical biotype (9, 17, 18, 21) . The importance of the toxin-coregulated pilus as a colonization factor for vibrios of the El Tor biotype has been questioned (7, 14, 18) ; it has been suggested that there are colonization factors other than the toxin-coregulated pilus that may be involved in colonization of the intestine by V. cholerae, especially of the El Tor biotype (3, 6, 8, 15) . One possible candidate may be the cell-associated hemagglutinin which is sensitive to D-mannose (MSHA) (11, 13) . This hemagglutinin is associated with the El Tor biotype and is strongly immunogenic (10) . Recently, we showed that MSHA is associated with pili that are expressed on the surface of most or all strains of El Tor bacteria grown both in vitro and in vivo during cholera infection (12) .
The aim of these studies was to determine whether specific antibodies to MSHA (polyclonal serum as well as monoclonal antibodies [MAb] (12, 20) ; ascites fluid that contained 27 mg of IgG3 per ml was produced by inoculating the hybrid cells into the peritoneal cavities of mice.
The specificity of the polyclonal antiserum and MAb 17:10, respectively, for MSHA has been amply documented by both functional and morphological criteria as described previously (12, 20) . The specificity of these immune reagents was further established in immunoblot analyses performed as described previously (12) using a crude MSHA preparation separated in a 17% polyacrylamide gel and subsequently transblotted to nitrocellulose paper essentially as described (22) . After being blocked with 1% bovine serum albumin-PBS, the nitrocellulose sheets were incubated for 2 h with antibodies and then incubated with anti-Ig horseradish peroxidase conjugates as secondary antibodies (Jackson Immuno Research Laboratories, West Grove, Pa.) and H202 with 4-chloro-1-naphthol (Bio-Rad Laboratories, Richmond, Calif.) as the enzyme substrate. As shown in Fig. 1 (1) . After centrifugation, the supernatant was filtered through a G25M Sephadex PD10 column (Pharmacia, Uppsala, Sweden).
The capacity of anti-MSHA antibodies to protect against experimental cholera was evaluated in infant mice (2) The results from the infant mouse studies indicate that the antibodies against MSHA had a protective effect against challenge with V. cholerae 01 bacteria of the El Tor but not the classical biotype. Protection against El Tor (strain 174) was observed with either absorbed polyclonal antiserum or MAb (Table 1) ; the effect was superior to that obtained with preimmune serum or MAb of irrelevant specificity. Although the MSHA preparation used to raise the polyclonal antiserum was not pure, the protection obtained with the absorbed antiserum was most likely due to specific antibodies against MSHA pili. Before use, the rabbit antiserum had been extensively absorbed with MSHA-negative bacteria so that, as specified above, the ELISA anti-LPS titer of the serum had been reduced 750-fold and no detectable vibriocidal activity remained. Furthermore, the absorbed antiserum had no protective effect against challenge with classical V. cholerae strains of homologous serotype that do not express MSHA (12, 13) (Table 1 ). The protective effect of MSHA antibodies was further supported by the finding that MAb 17:10 substantially reduced mortality in the mice infected with El Tor but not in mice infected with classical vibrios. The MAb ascites fluid used also lacked vibriocidal activity and did not react against LPS in ELISA although it reacted strongly with MSHA in ELISA (Table 1) and immunoblot tests (Fig. 1) .
To determine whether the protective effect of MSHA antibodies against experimental El Tor cholera was due to specific blocking of fimbrial attachment to the intestinal epithelium preventing colonization or to bacterial agglutina- tion, we prepared Fab fragments of the polyclonal anti-MSHA serum and tested them for protective effect against El Tor challenge in infant mice. The fragments did not agglutinate MSHA-positive bacteria but were able to inhibit hemagglutination by MSHA-expressing bacteria and also reacted strongly with the MSHA subunit in Western immunoblots (Fig. 1, lane 4) . When tested in an Ig concentration corresponding to that of the MSHA antiserum, the Fab fragments were also found to offer significant protection against challenge with the El Tor strain 174 (Table  2) . Protective efficacies in the presence of Fab fragments and total anti-MSHA antiserum were 64 and 100%, respectively, compared with that in the presence of the preimmune serum.
The results from the infant mouse cholera model were confirmed when the protective effect of antibodies against MSHA was tested in the rabbit ileal loop model. This was done by evaluating the capacity of the anti-MSHA rabbit serum and MAb 17:10 to inhibit fluid secretion in ileal loops challenged with the different El Tor and classical V. cholerae strains (Table 3 ). It was shown that the polyclonal antiserum had a very strong protective effect against challenge with bacteria of the El Tor biotype, while no such effect was seen when classical strains were tested. Thus, the dose of the different challenge strains (i.e., 174 and T19479) giving half-maximal fluid accumulation (ED50) in the loops increased 14 and 80 times, respectively, in the presence of rabbit antiserum to MSHA fimbriae compared with that in preimmune serum. When the MAb was used, the protective effect was less pronounced, with 3.5-and 2-fold-increased ED50 values in the presence of the specific MAb compared with the nonspecific MAb; the serum and MAb were not protective against two classical strains tested (Table 3) .
Using two different animal cholera infection models, we found that a MAb and an extensively absorbed antiserum against MSHA pili were able to protect animals against challenge with El Tor but not with classical V. cholerae strains. This is analogous to results from a previous study (12) 
